These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24966187)

  • 1. Selection of HBV preS1-binding penta-peptides by phage display.
    He Y; Ye X; Tiollais P; Zhang J; Zhang J; Liu J; Xie Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):691-8. PubMed ID: 24966187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R; Kawano T; Kang JH; Murata M
    World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for PreS specific binding ligands with a phage displayed peptides library.
    Deng Q; Zhuang M; Kong YY; Xie YH; Wang Y
    World J Gastroenterol; 2005 Jul; 11(26):4018-23. PubMed ID: 15996026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking peptides against HBV: preS1 protein selected from a phage display library.
    Wang W; Liu Y; Zu X; Jin R; Xiao G
    Biochem Biophys Res Commun; 2011 Sep; 412(4):633-7. PubMed ID: 21856287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.
    Deng Q; Zhai JW; Michel ML; Zhang J; Qin J; Kong YY; Zhang XX; Budkowska A; Tiollais P; Wang Y; Xie YH
    J Virol; 2007 Apr; 81(8):4244-54. PubMed ID: 17192308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus.
    Kang JH; Toita R; Asai D; Yamaoka T; Murata M
    J Virol Methods; 2014 Jun; 201():20-3. PubMed ID: 24568971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells.
    Tang KH; Yusoff K; Tan WS
    J Virol Methods; 2009 Aug; 159(2):194-9. PubMed ID: 19490973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
    Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
    J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.
    Ye X; Zhou M; He Y; Wan Y; Bai W; Tao S; Ren Y; Zhang X; Xu J; Liu J; Zhang J; Hu K; Xie Y
    Sci Rep; 2016 Jul; 6():29391. PubMed ID: 27384014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on HBV preS/S gene mutation in peripheral blood mononuclear cells].
    Zhang L; He L; Yao X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):148-52. PubMed ID: 12569784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.
    Gerken G; Kremsdorf D; Capel F; Petit MA; Dauguet C; Manns MP; Meyer zum Büschenfelde KH; Brechot C
    Virology; 1991 Aug; 183(2):555-65. PubMed ID: 1853561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of the preS1 peptide of hepatitis B surface antigen in Escherichia coli.
    Lin Y; Liu YX; Cislo T; Mason BL; Yu MY
    J Med Virol; 1991 Mar; 33(3):181-7. PubMed ID: 1880495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection.
    Pollicino T; Campo S; Raimondo G
    Virology; 1995 Apr; 208(2):672-7. PubMed ID: 7747438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV surface antigen proteins with deletions in the preS region.
    Xu K; Yu X; Kong Y; Wang Y; Li Z
    Sci China B; 1995 Mar; 38(3):320-7. PubMed ID: 7766314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A; Gazina E; Milanesi G
    Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity maturation of an anti-hepatitis B virus PreS1 humanized antibody by phage display.
    Yang GH; Yoon SO; Jang MH; Hong HJ
    J Microbiol; 2007 Dec; 45(6):528-33. PubMed ID: 18176536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
    Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
    Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.
    Mun HS; Lee SA; Jee Y; Kim H; Park JH; Song BC; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Kook YH; Kim BJ
    J Med Virol; 2008 Jul; 80(7):1189-94. PubMed ID: 18461612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.